Rs. Farid et al., DIFFERENTIAL BINDING OF HMG1, HMG2, AND A SINGLE HMG BOX TO CISPLATIN-DAMAGED DNA, Toxicology and applied pharmacology, 141(2), 1996, pp. 532-539
The HMG box domain is a DNA binding domain present in the nonhistone c
hromosomal proteins HMG1 and HMG2 and in other proteins involved in th
e regulation of gene expression. Previous studies have demonstrated th
at HMG1 and HMG2 bind with high affinity to DNA modified with the canc
er chemotherapeutic drug cisplatin (CDDP). In this report, we compare
the binding of full-length HMG1 and HMG2 and the HMG boxes present in
these proteins to that of CDDP-DNA. Complexes between HMG1, HMG2, or H
MG Box A + B and CDDP-DNA were stable at greater than or equal to 500
mM salt, while complexes between a single HMG box and CDDP-DNA exhibit
ed decreased stability, Analysis of a series of HMG1 Box A mutant cons
tructs revealed different affinities for CDDP-DNA. Two constructs cont
aining a Phe to Ala substitution at position 19 and a Tyr to Gly subst
itution at position 71, are noteworthy; these peptides exhibited reduc
ed affinity for CDDP-DNA. We have generated a structure of HMG1 Box A
and used it, along with the results of our binding studies, to model i
ts interaction with CDDP-DNA. HMG1 Box A binds in the minor groove of
CDDP-DNA, in agreement with earlier studies. Our model predicts that T
yr71 partially intercalates and forms an H bond with the sugar-phospha
te backbone. The model also suggests that Phe 19 does not directly int
eract with DNA, and hence an Ala substitution at position 19 may alter
protein structure. This model should provide a framework for future s
tudies examining HMG Box-DNA interactions. (C) 1996 Academic Press, In
c.